Kewaunee Scientific Corp. (DE:KEW)
FRANKFURT:KEW
KEW Stock Chart & Stats
€36.20
€0.50(0.85%)
At close: 4:00 PM EST
€36.20
€0.50(0.85%)
Day’s Range― - ―
52-Week Range€28.20 - €50.50
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€89.27M
Enterprise Value€165.28M
Total Cash (Recent Filing)€10.35M
Total Debt (Recent Filing)€59.34M
Price to Earnings (P/E)9.3
Beta0.57
Next Earnings
Jun 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.87
Shares Outstanding2,866,384
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.20
Price to Book (P/B)1.41
Price to Sales (P/S)0.38
P/FCF Ratio7.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthSustained ~78% TTM revenue growth indicates expanding commercial traction and project wins across lab build-outs. Over the next several months this scale should improve pricing leverage, utilization and backlog visibility, supporting recurring project execution and margin recovery.
Robust Cash GenerationConsistent positive operating and free cash flow provides durable internal funding for working capital, installation capex, and strategic initiatives. Solid FCF reduces reliance on external financing and underpins the company’s ability to execute multi-month projects and pursue selective M&A or reinvestment.
Acquisition Broadens Product EcosystemIntegration of Nu Aire expands product breadth and creates a more integrated lab solutions offering, supporting higher specification win-rates on construction projects. Structurally this enhances cross-sell potential and differentiation on turnkey lab builds over a multi-month horizon.
Bears Say
Rising LeverageHigher debt-to-equity (~0.84) raises financial risk if project activity softens. Increased leverage constrains flexibility for cyclicality, amplifies interest cost exposure and limits capacity to fund large project backlogs or absorb cost inflation without pressuring cash flow or requiring external capital.
Modest, Volatile Net MarginsLow net margin (~3.9%) leaves earnings finely exposed to material, labor and freight cost swings and project-mix shifts. Margin volatility reduces predictability of free cash flow and makes multi-month planning for reinvestment or debt reduction more challenging in a project-driven business.
Revenue Tied To Capital Spending CyclesDependence on institutional and private capital expenditure creates lumpy, cyclical revenue and backlog timing risks. Long project cycles and competitive specification processes can cause uneven cash conversion and make near-term demand sensitive to public and private capex trends over the coming months.
Kewaunee Scientific News
KEW FAQ
What was Kewaunee Scientific Corp.’s price range in the past 12 months?
Kewaunee Scientific Corp. lowest stock price was €28.20 and its highest was €50.50 in the past 12 months.
What is Kewaunee Scientific Corp.’s market cap?
Kewaunee Scientific Corp.’s market cap is €89.27M.
When is Kewaunee Scientific Corp.’s upcoming earnings report date?
Kewaunee Scientific Corp.’s upcoming earnings report date is Jun 23, 2026 which is in 12 days.
How were Kewaunee Scientific Corp.’s earnings last quarter?
Kewaunee Scientific Corp. released its earnings results on Mar 11, 2026. The company reported €0.201 earnings per share for the quarter, beating the consensus estimate of N/A by €0.201.
Is Kewaunee Scientific Corp. overvalued?
According to Wall Street analysts Kewaunee Scientific Corp.’s price is currently Overvalued.
Does Kewaunee Scientific Corp. pay dividends?
Kewaunee Scientific Corp. does not currently pay dividends.
What is Kewaunee Scientific Corp.’s EPS estimate?
Kewaunee Scientific Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kewaunee Scientific Corp. have?
Kewaunee Scientific Corp. has 2,866,384 shares outstanding.
What happened to Kewaunee Scientific Corp.’s price movement after its last earnings report?
Kewaunee Scientific Corp. reported an EPS of €0.201 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -12.637%.
Which hedge fund is a major shareholder of Kewaunee Scientific Corp.?
Currently, no hedge funds are holding shares in DE:KEW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kewaunee Scientific Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.12%
12-Months-Change
Fundamentals
Return on Equity
16.29%
Trailing 12-Months
Asset Growth
-6.97%
Trailing 12-Months
Company Description
Kewaunee Scientific Corp.
Kewaunee Scientific Corporation, established in 1906 and based in Statesville, North Carolina, specializes in providing custom furniture and infrastructure systems for scientific, medical, and technical settings. The company manages its operations through distinct domestic and international divisions. Its extensive product line features diverse furniture options crafted from steel, wood, and laminate, along with specialized equipment like fume hoods, biological safety cabinets, laminar flow systems, and ductless hoods. Kewaunee also offers versatile modular and column systems, mobile workstations, carts, durable epoxy resin worksurfaces, sinks, and various accessories, all supported by comprehensive design assistance. These solutions serve a broad client base: Laboratory products are essential for chemistry, physics, biology, and other general science research conducted in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, governmental, and healthcare industries. Technical products are utilized in facilities manufacturing computers and light electronics, as well as by those requiring furniture for computer and networking setups. Laminate casework applications extend to educational, healthcare, and industrial environments. The corporation primarily distributes its offerings through a network of independent dealers, its own subsidiary companies, and a major national distributor.
Technical Analysis
Bassett Furniture
―
Ethan Allen
―
Flexsteel
―
Hooker Furniture
―
Virco Manufacturing
―
Options Prices
Currently, No data available
---